Graphy Inc.

Graphy Inc.

KKRX:318060
9,030.00
KRW
-1,130.00
(-11.12%)
-1,040.41EPS
189.06BMarket Cap
2024 Y
2025 Y
TTM
Revenue per Share
3,356.27
2,093.77
2,163.22
Basic EPS, GAAP
-6,799
-1,190
-1,040.41
Free Cash Flow per Basic Share
-2,051.32
-1,840.51
-2,316.94
Dividend per Share
- -
- -
- -
Book Value per Share
349.42
1,891.81
1,356.48
Tangible Book Value per Share
316.11
1,840.85
1,314.63
Basic Weighted Avg Shares
5
10
11
Sales/Revenue/Turnover
16,125
20,533
23,511
Operating Margin (%)
-56.87
-53.83
-50.08
Depreciation Expense
901
1,058
1,079
Net Income, GAAP
-32,664
-11,670
-11,308
Effective Tax Rate (%)
- -
- -
- -
Profit Margin (%)
-202.58
-56.84
-48.1
Working Capital
-6,649
8,297
2,527
LT Debt
111
236
189
Total Equity
3,857
21,052
15,095
Return on Invested Capital (%)
- -
- -
- -
Return on Capital (%)
- -
- -
- -
Return on Common Equity (%)
- -
-93.7
- -

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
12,932
11,515
10,887
LT Borrowings
- -
- -
- -
LT Finance Leases
236
223
189
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
273,187
476,825
189,061

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
26,511
21,632
18,302
Cash, Cash Equivalents & STI
13,097
6,950
965
Accounts Receivable, Net
8,854
9,255
11,515
Inventories
3,357
3,203
3,766
Total Current Liabilities
18,213
15,971
15,775
Payables & Accruals
- -
- -
- -
ST Debt
12,932
11,515
10,887
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
445.78%
Free Cash Flow
- -
- -
83.14%
Net Income, GAAP
- -
- -
-64.27%
Sales/Revenue/Turnover
- -
- -
27.34%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
16,125
2025
2,274
- -
3,440
10,440
20,533
2026
3,353
6,279
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-6,799
2025
-345.15
- -
-356.24
-120.48
-1,190
2026
-253.57
-319
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Woon-Sep Shim
Full Time Employees
119
Sector
Process industries
Industry
Chemicals: specialty
Address
Seoul South Korea
IPO Date
Aug 25, 2025
Business
Graphy Inc. is a South Korea-based advanced materials and medical technology company specializing in the development, manufacture, and commercialization of photocurable polymer materials and 3D printing solutions for the global dental and healthcare industries. Founded in 2017 and headquartered in Seoul, South Korea, the company operates through its digital dentistry and advanced additive manufacturing segments, serving dental clinics, orthodontic practices, commercial dental laboratories, and medical device manufacturers across Asia-Pacific, North America, Europe, the Middle East, and Latin America. The company offers a comprehensive range of proprietary photopolymers, hardware, and digital workflow solutions, organized primarily under its flagship Tera Harz brand, including: direct 3D printed shape memory clear aligner materials (Tera Harz TC-85DAC and TC-85DAW), which enable the direct additive manufacturing of orthodontic aligners with thermal shape memory recovery properties, bypassing conventional thermoforming processes; permanent and temporary crown and bridge photopolymer resins (Tera Harz TC-80CB); denture base and artificial teeth materials for full and partial removable prosthetics; biocompatible dental model, surgical guide, splint, and custom tray resins; specialized post-processing and curing hardware, including high-output nitrogen-atmosphere UV post-curing systems (Tera Harz Cure); precision dental 3D printing systems; and integrated digital orthodontic CAD/CAM software compatibility tools, clinical training, and technical support services. In recent developments, Graphy Inc. completed its public listing on the KOSDAQ market (KRX:318060) to accelerate global commercialization and scale manufacturing capabilities. The company has broadened its international regulatory approvals, obtaining United States Food and Drug Administration (FDA) 510(k) clearances and European Union Medical Device Regulation (EU MDR) CE certifications for its proprietary shape memory aligner materials and dental prosthetic resins. In addition, Graphy Inc. has expanded its global footprint through strategic distribution agreements, education center partnerships, and commercial supply alliances with leading dental laboratories and distributors across North America and Europe, while introducing next-generation shape memory resin formulations and automated post-curing units to optimize digital orthodontic workflows.